2 FTSE 100 stocks I’d buy to build wealth in the long run

After the market sell-off, I’m looking at cheap FTSE 100 stocks to help my portfolio grow over the long run and, if I’m lucky, retire early.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Mature people enjoying time together during road trip

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The FTSE 100 hasn’t had a great month. In fact, it’s down around 5% over the last 30 days after a series of negative announcements triggered a global sell-off.

However, stock market volatility also provides an opportunity to buy. And even before the sell-off, I saw the FTSE 100 as a great place to find dividend-paying value stocks for my portfolio.

So here are two lead index stocks I’m looking to add to my portfolio to build wealth over the long run. Both are down in recent months, neither are paying anything special in terms of dividends, but I think they will perform well over the next three-to-five years.

Smith & Nephew

Smith & Nephew (LSE:SN) stock is trading near its year-low, but things are looking brighter for this medical device manufacturer. The stock fell 10% in June amid a global sell-off. But I think this represents a good chance to buy.

The firm is still reeling from the impact of Covid-19. The virus brought a halt to elective medical procedures and this still impacts the sector today. In 2020, Smith & Nephew saw pre-tax profits fall to $246m, from $743 in 2019. 

But cancellations are becoming less common and hospitals are increasingly adept at dealing with the virus and its impact. Profits doubled to $586m in 2021, despite record Covid hospitalisations in the UK and elsewhere in Europe.

The latest news has been positive too. In April, Smith & Nephew said Q1 revenue rose 5.9% year-on-year to $1.31bn. This was above analysts’ forecasts of $1.27bn. The firm also said emerging markets revenue was up 14.3%.

With performance not yet back to pre-pandemic levels, Smith & Nephew doesn’t offer the best dividend yield. At today’s price, it’s around 2.5%. But I’d expect to see that rise as operating conditions improve.

Burberry

Burberry (LSE:BRBY) is one of the most iconic brands around. But at the moment, outlook for the luxury fashion house is very dependent on the Chinese economy. With China imposing lockdowns every time authorities come across a cluster of Covid-19 cases, it doesn’t look too positive.

However, I think this has been factored into the share price already. The stock is down 25% over the past year with China wrestling with Covid-19 and other economic pressures, notably the property sector.

But this is also a highly profitable business with impressive margins. Currently, the firm has a price-to-earnings (P/E) ratio of 13.5. By comparison, luxury goods group Kering, which owns dozens of high-end brands, has a P/E ratio of around 20. While less diversified that the French conglomerate, Burberry certainly looks a lot cheaper.

The weakness of the British pound may also offset a near-term fall in sales.

But in the long run, I think Burberry is a brand that will continue to deliver. It has successfully transformed itself into a modern business that attracts customers from all age groups across the globe.

The dividend is a meagre 2.5% right now. But, like Smith & Nephew, I’d expect to see that rise as the operating environment improves.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

James Fox owns shares in Smith & Nephew. The Motley Fool UK has recommended Burberry and Smith & Nephew. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The Rolls-Royce share price hit new highs in November. What next?

November has been another record-breaking month for the Rolls-Royce share price. And the outlook for 2025 still looks bright.

Read more »

Investing Articles

Here’s the growth forecast for Sage Group shares to 2026!

Sage Group shares have rocketed following the tech firm's stunning third-quarter update. Is now the time to consider buying in?

Read more »

Investing Articles

10%+ dividend growth! 2 FTSE 250 shares tipped to turbocharge dividends

These FTSE 250 income shares look in great shape to grow their dividends by double-digit percentages, says our writer Royston…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Would it be madness to buy this FTSE stock smashed by Donald Trump’s team picks?

Ben McPoland takes a look at one FTSE share inside his portfolio that has been battered lately due to a…

Read more »

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »